Anxiety and Insomnia: Why Can't You Sleep? Causes, Diagnosis, and Treatment

What is anxiety and insomnia?

An adequate night’s rest is one of the most fundamental requirements for physical and mental health. Yet, for millions of people, the simple act of falling and staying asleep has become a nightly source of frustration, fear, and suffering. There is a particular and painful irony in insomnia: the harder you try to sleep, the more elusive sleep becomes. The anxiety about not sleeping often becomes more disruptive than the sleeplessness itself.

Before exploring the complex relationship between anxiety and sleep, it is important to establish a reassuring baseline: occasional sleeplessness is entirely normal and not cause for alarm. Almost everyone experiences a night of restless, disrupted, or minimal sleep at some point, whether before a stressful event, after an emotional shock, during travel across time zones, or for no identifiable reason. The human body is remarkably resilient and fully capable of recovering from an isolated night of poor sleep. Most people who occasionally wake during the night or take longer than usual to fall asleep do not actually have an insomnia disorder, and many people do not even remember brief nocturnal awakenings the next morning.

Clinical insomnia is a different and more significant matter. People with genuine insomnia experience persistent and recurrent difficulties with sleep that are not explained by their circumstances and that cause meaningful daytime consequences. Clinically, this manifests in one or more of the following ways:

• Sleep onset difficulty: Taking an excessively long time, typically defined as more than 20 to 30 minutes, to fall asleep after going to bed
• Sleep maintenance difficulty: Waking up frequently during the night and having difficulty returning to sleep
• Early morning awakening: Waking significantly earlier than intended (typically one or more hours before the desired wake time) and being unable to fall back asleep
• Non-restorative sleep: Spending adequate time in bed but consistently waking feeling unrefreshed, unrestored, and tired

When these difficulties occur at least three nights per week, persist for at least three months, and produce significant daytime impairment (fatigue, mood disturbance, cognitive difficulties, or interference with work, relationships, or social functioning), the diagnosis of chronic insomnia disorder applies.

A crucial psychological trap that perpetuates and amplifies insomnia is the development of performance anxiety around sleep. When sleep difficulties begin, often initially triggered by a period of stress or anxiety, many individuals understandably start to worry about their sleep. They begin monitoring their sleep, watching the clock, catastrophizing about the consequences of not sleeping (“If I don’t fall asleep now, I won’t be able to function tomorrow”), and dreading bedtime. This sleep-related anxiety activates the body’s arousal and stress response at precisely the time when physiological quieting is required, creating a vicious cycle from which it can be very difficult to escape without guidance.

Breaking unhelpful thought patterns is therefore a critical first step. Instead of thinking: “I must fall asleep now or tomorrow will be ruined”, practice replacing this with: “I have coped well after difficult nights before, and I will manage tomorrow too”. Other counterproductive thought patterns to actively challenge include:

• Catastrophizing about the severity, permanence, or consequences of insomnia: In the majority of cases, insomnia is both temporary and treatable.
• Blaming all daytime difficulties (mood, concentration, memory) entirely on lack of sleep: Anxiety and worry contribute at least as much to these difficulties as sleep deprivation itself.
• Assuming you need exactly 8 to 10 hours of sleep: Sleep needs are highly individual. If you consistently sleep less than this and feel well, rested, and functional during the day, your individual sleep requirement may simply be lower.

Stress and anxiety can cause sleep disorders, and existing sleep disorders can be significantly worsened by anxiety. Understanding this bidirectional relationship is the foundation of effective management.

---

How Many Hours of Sleep Do You Actually Need?

Sleep requirements are not fixed but vary substantially across individuals, across developmental stages, and across the lifespan. There is no single correct number of hours that applies universally to all adults. The following evidence-based guidelines from the American Academy of Sleep Medicine and the Sleep Research Society reflect population-level recommendations:

A widely held belief that older adults require substantially less sleep than younger adults is not supported by the current scientific evidence. Older individuals need approximately the same total duration of sleep as younger adults. However, the architecture of sleep does change with aging: the proportion of deep, slow-wave sleep (Stage 3 NREM) decreases progressively with age, making sleep lighter and more easily disrupted. This explains why older adults often experience more frequent nighttime awakenings: not because they need less sleep, but because their sleep is more fragile.

Individual variation around these averages is also important to acknowledge. Some genuinely healthy individuals function optimally on 6 hours of sleep; others require 9 or 10 hours. What matters clinically is not the absolute number but whether the individual feels adequately rested and functions well during the day.

The most reliable signs of insufficient sleep include:

• Difficulty waking in the morning without an alarm
• Falling asleep within minutes of sitting quietly
• Significantly increased sleep on weekends or days off (so-called “sleep debt”)
• Chronic daytime fatigue, irritability, or difficulty concentrating

---

What Is an Anxiety Disorder?

Anxiety disorders are a group of distinct but related psychiatric conditions unified by the presence of excessive, persistent, irrational, and difficult-to-control fear, worry, or anxiety that is disproportionate to any actual threat and that causes significant distress or functional impairment. They are the most common mental health conditions globally, affecting an estimated 1 in 3 individuals at some point in their lifetime.

It is essential to distinguish between normal anxiety, which serves an important adaptive and protective function (motivating preparation for exams, fueling appropriate caution in dangerous situations, and facilitating social performance), and pathological anxiety. The latter is disproportionate, self-perpetuating, difficult to control, and interferes with normal functioning rather than enhancing it.

The major categories of anxiety disorders include:

• Generalized Anxiety Disorder (GAD): Persistent, uncontrollable worry about multiple domains of life (health, finances, work, relationships, the future) for at least six months, accompanied by physical symptoms such as muscle tension, fatigue, irritability, concentration difficulties, and sleep disturbances.

• Obsessive-Compulsive Disorder (OCD): Recurrent intrusive thoughts, images, or urges (obsessions) that cause significant anxiety, neutralized by repetitive behavioral or mental rituals (compulsions) that temporarily reduce distress but reinforce the cycle.

• Panic Disorder: Recurrent, unexpected panic attacks, which are sudden surges of intense fear or physical discomfort (e.g., racing heart, difficulty breathing, chest pain, dizziness, or a feeling of impending doom or death). These attacks reach peak intensity within minutes and are followed by persistent anticipatory anxiety about further attacks.

• Post-Traumatic Stress Disorder (PTSD): Develops following exposure to severe trauma (violence, accidents, disasters, assault) and is characterized by intrusive re-experiencing (flashbacks, nightmares), persistent avoidance of trauma-related reminders, hyperarousal, and negative alterations in cognition and mood. Sleep disturbances, particularly nightmares and hypervigilance, are cardinal features of PTSD.

• Social Anxiety Disorder (SAD): Intense, persistent fear of social or performance situations where the individual fears being scrutinized, judged negatively, humiliated, or embarrassed.

• Specific Phobias: Intense, circumscribed fears of specific objects or situations (heights, animals, blood, flying, confined spaces, etc.) that prompt significant avoidance behavior.

Anxiety disorders are genuine medical conditions, not character weaknesses or choices, and are associated with identifiable neurobiological changes in brain circuits governing fear, threat detection, and emotional regulation. Crucially, the vast majority of anxiety disorders are highly treatable with evidence-based interventions.

---

What Is a Sleep Disorder?

A sleep disorder is any condition in which normal sleep patterns are sufficiently disturbed to significantly impair physical, mental, or emotional functioning. Sleep disorders are far more common than generally recognized, affecting approximately one in three adults at some point in their lives.

Insomnia

The most prevalent sleep disorder, insomnia is defined by:

• Difficulty initiating sleep (sleep-onset insomnia)
• Difficulty maintaining sleep, such as frequent awakenings or prolonged wakefulness during the night (sleep maintenance insomnia)
• Early morning awakening with inability to return to sleep
• Non-restorative sleep, feeling unrefreshed despite spending adequate time in bed

For clinical significance, these difficulties must occur despite adequate opportunity and circumstances for sleep, cause daytime functional impairment, and not be better explained by another sleep disorder or medical condition.

Acute (short-term) insomnia is extremely common and is often triggered by identifiable stressors, such as a stressful life event, illness, travel, or environmental changes. It typically resolves when the precipitating factor resolves, though in some individuals it can become self-perpetuating and transition to chronic insomnia.

Chronic insomnia persists for at least three months, occurring at least three nights per week, and is often maintained by learned behaviors and cognitive patterns (such as clock-watching, excessive time in bed, and catastrophic thinking about sleep) that were initially adaptive but have become self-perpetuating.

Other Sleep Disorders

Beyond insomnia, the clinical classification of sleep disorders includes:

• Hypersomnia: Excessive daytime sleepiness despite adequate (or even prolonged) nighttime sleep. The complaint is not difficulty sleeping but rather excessive sleeping or irresistible daytime drowsiness.
• Obstructive Sleep Apnea (OSA): Characterized by repeated partial or complete collapse of the upper airway during sleep, producing characteristic snoring, choking, or gasping, and causing fragmented sleep with excessive daytime sleepiness. An important and frequently underdiagnosed cause of both insomnia and anxiety symptoms.
• Narcolepsy: A chronic neurological disorder of sleep-wake regulation causing overwhelming daytime sleepiness and sudden, uncontrollable episodes of sleep. Often associated with cataplexy (sudden muscle weakness triggered by emotion).

The parasomnias are a group of disorders involving abnormal behaviors, movements, perceptions, or emotions occurring during sleep or the transitions between sleep and wakefulness:

• Bruxism: Involuntary teeth grinding or clenching during sleep, often causing dental damage and jaw pain
• Nocturnal enuresis: Bedwetting during sleep
• Nightmares and nightmare disorder: Recurrent, distressing dreams that cause significant awakening and distress
• Sleep terror (pavor nocturnus): Episodes of sudden arousal from deep sleep with intense fear, screaming, and autonomic activation. The individual is usually inconsolable and has no memory of the episode.
• Restless Legs Syndrome (RLS): Uncomfortable, irresistible urge to move the legs, typically worse at rest and in the evening or night, causing significant sleep onset difficulty
• Somnambulism (sleepwalking): Episodes of complex behaviors (including walking) performed during sleep without awareness
• Somniloquy (sleep talking): Vocalizations during sleep without conscious awareness
• Sexsomnia: Sexual behaviors during sleep without conscious awareness (a rare parasomnia with significant interpersonal and legal implications)

---

Does Anxiety Cause Sleep Problems, or Do Sleep Problems Cause Anxiety?

This is one of the most clinically important questions in sleep medicine, and the answer is nuanced: both scenarios are possible and well-documented. The relationship between anxiety and insomnia is bidirectional: each can cause, worsen, and perpetuate the other, creating a mutually reinforcing cycle that can be difficult to interrupt.

Anxiety implies Sleep Disruption

Anxiety activates the hypothalamic-pituitary-adrenal (HPA) axis and the sympathetic nervous system, the body’s primary stress response systems. This activation produces:

• Physiological hyperarousal: Elevated heart rate, increased body temperature, heightened muscle tension, and accelerated metabolism are all incompatible with the physiological quieting required for sleep onset.
• Cognitive hyperactivation: Racing thoughts, worry, rumination, and intrusive mental content that prevent the mental disengagement necessary for sleep
• Cortisol dysregulation: Elevated evening cortisol (which should be at its daily nadir near bedtime) suppresses melatonin secretion and prevents the normal transition into sleep.
• Hypervigilance: An exaggerated state of alertness and threat-monitoring that makes the brain resistant to the state of vulnerability that sleep requires.

Among individuals with anxiety disorders, sleep disturbances are nearly universal. Specific anxiety disorders produce characteristic sleep disruption patterns:

• GAD: Predominantly sleep onset insomnia. The worry and racing thoughts that characterize GAD intensify when external distractors are removed at bedtime.
• PTSD: Nightmares directly related to the traumatic experience, hypervigilance-driven sleep maintenance difficulties, and fear of sleep itself (due to anticipation of nightmares) are hallmark features.
• Panic Disorder: Nocturnal panic attacks, which occur without any identifiable trigger during sleep, can create a profound fear of sleeping.
• OCD: Bedtime rituals and obsessional rumination can dramatically delay sleep onset.

Sleep Disruption implies Anxiety

The causal arrow also runs in the opposite direction, and this may be less intuitively obvious but is equally well-supported by evidence. Sleep deprivation and insomnia:

• Amplify amygdala reactivity: The amygdala, the brain’s primary threat-detection and fear-processing center, shows markedly increased reactivity to emotionally negative stimuli after sleep deprivation. This makes individuals who are sleep-deprived both more emotionally reactive and more prone to perceiving neutral stimuli as threatening.
• Impair prefrontal cortical control: The prefrontal cortex, which normally modulates and regulates amygdala responses, is particularly vulnerable to sleep loss. This reduces its capacity to exert top-down inhibitory control over fear and anxiety responses.
• Alter neurochemical balance: Chronic sleep deprivation depletes serotonin, reduces GABA-ergic inhibitory tone, and elevates norepinephrine, creating a neurochemical milieu that predisposes to anxious arousal.

Research demonstrates that people with chronic insomnia have significantly elevated rates of developing anxiety disorders over time. The insomnia appears to function as a genuine risk factor rather than merely a symptom. Similarly, experimental sleep deprivation reliably induces anxiety-like states in healthy volunteers.

The Vicious Cycle

For individuals with anxiety disorders, insomnia creates a particularly cruel self-reinforcing cycle:

1. Anxiety makes sleep difficult through the mechanisms above.
2. Poor sleep worsens anxiety, increasing emotional reactivity, worry, and physiological arousal.
3. Worry about sleep becomes an additional source of anxiety, as the individual begins to dread bedtime, monitor their sleep compulsively, and catastrophize about the consequences of not sleeping.
4. This sleep-specific anxiety further disrupts sleep because the attempt to control sleep creates the very arousal that prevents it.
5. Daytime impairment from poor sleep creates further stressors (impaired work performance, relationship difficulties, mood disturbance) that fuel anxiety.
6. The cycle continues and deepens

This self-sustaining cycle is one of the most important therapeutic targets in treating anxiety-related insomnia, and explaining it to patients (a process called psychoeducation) is itself a therapeutically meaningful first step.

It is also worth noting that several antidepressants commonly prescribed for anxiety disorders can themselves cause or worsen sleep difficulties, particularly SSRIs and SNRIs (which can cause insomnia, vivid dreams, or akathisia) and bupropion (which has activating properties). This medication-related sleep disruption may temporarily worsen the very anxiety it is intended to treat, and requires careful management.

---

Can Insomnia Lead to Other Health Problems?

Beyond the obvious and immediate consequences of daytime fatigue and tiredness, chronic insufficient sleep or insomnia is associated with a broad spectrum of serious adverse health consequences, many of which go far beyond what most people appreciate.

Cognitive and Occupational Consequences

• Reduced reaction time and psychomotor vigilance significantly increase the risk of workplace accidents and motor vehicle crashes. (Sleepy driving is as dangerous as drunk driving by many metrics)
• Impaired working memory, executive function, and decision-making ability
• Reduced creativity and problem-solving capacity
• Impaired academic or work performance

Mental Health Consequences

The bidirectional relationship with anxiety has been discussed above. Beyond anxiety, chronic insomnia is an independent risk factor for:

• Major depression: Insomnia is one of the strongest modifiable risk factors for the development of depression. People with chronic insomnia are approximately 5 times more likely to develop depression than those without insomnia.
• Suicidal ideation: Sleep disturbances (particularly insomnia and nightmares) are associated with increased suicidal thinking, independent of depression.
• Increased vulnerability to substance misuse (alcohol and sedative use to facilitate sleep is a common but counterproductive coping strategy).

Cardiovascular Disease

Chronic sleep restriction and insomnia are independently associated with significantly elevated risks of:

• Heart failure: Both short sleep duration and insomnia are associated with elevated inflammatory markers and sympathetic nervous system activation that stress the cardiovascular system
• Cardiac arrhythmias: Including atrial fibrillation
• Myocardial infarction (heart attack): Multiple large-scale epidemiological studies link chronically short sleep duration with increased myocardial infarction risk
• Stroke: Both too little and too much sleep are independently associated with elevated stroke risk
• Hypertension: Short sleep duration is associated with elevated blood pressure, partly through sustained sympathetic activation

Metabolic Consequences

• Obesity: Adults who habitually sleep fewer than 6 hours per night have significantly higher rates of obesity than those sleeping 7 to 8 hours. The mechanisms are multiple: sleep deprivation alters the hormonal regulation of appetite, reducing leptin (the satiety hormone) and increasing ghrelin (the hunger hormone), creating a biological drive toward overeating and specifically toward calorie-dense foods.
• Type 2 diabetes: Insufficient sleep impairs insulin sensitivity and glucose metabolism, independently predicting the development of type 2 diabetes.

Immune System Consequences

During sleep, the body performs critical immune maintenance functions:

• Growth hormone secretion: The majority of daily growth hormone, which is essential for tissue repair, muscle growth, and cellular regeneration, is secreted during deep slow-wave sleep. Chronic sleep deprivation therefore impairs the body’s physical repair capacity.
• Immune cytokine production: Certain immune-regulating proteins (including some interleukins and tumor necrosis factor) are preferentially produced during sleep, supporting immune surveillance and response.
• Leptin production: Beyond its role in appetite regulation, leptin has important immune-modulatory functions.

Experimental studies demonstrate that sleep-deprived individuals mount significantly weaker immune responses to vaccinations and are more susceptible to viral infections when experimentally challenged. The well-known subjective experience that “a good night’s sleep” helps recovery from illness reflects genuine biological reality.

---

Diagnosis

The diagnosis of anxiety-related insomnia requires a comprehensive clinical assessment rather than any single test. The evaluating clinician, who may be a primary care physician, psychiatrist, psychologist, or sleep medicine specialist, aims to characterize the sleep disorder. This includes assessing its nature, pattern, severity, and duration. They also work to identify its relationship to anxiety and other contributing factors, as well as rule out organic medical causes of sleep disturbance.

Detailed Clinical History

The foundation of diagnosis is a thorough interview exploring:

• Sleep patterns and history: Usual bedtime and wake time, time taken to fall asleep, frequency and duration of nighttime awakenings, early morning awakening pattern, total estimated sleep time, daytime functional consequences
• Symptom onset and course: When did the sleep problem begin? Was there an identifiable precipitant? How has it evolved over time?
• Associated anxiety symptoms: The presence of worry, racing thoughts, physical tension, palpitations, hypervigilance, and anticipatory anxiety, particularly around sleep.
• Daytime behaviors: Napping habits, time in bed, level of physical activity.
• Lifestyle factors: Caffeine consumption (amount, timing, sources), alcohol intake, exercise habits, work schedule, shift work or irregular hours.
• Medication review: Current prescription medications (many can disrupt sleep or cause anxiety), over-the-counter medications, supplements, and recreational substances.
• Bedroom environment: Light, noise, temperature, comfort, use of screens in bed.
• Medical history: Chronic pain conditions, respiratory conditions, urological symptoms (frequent nocturia), hormonal changes (menopause), thyroid disease, and neurological conditions all contribute to sleep disruption.

Sleep Diary

A prospective sleep diary, kept by the patient for 1 to 2 weeks before the evaluation appointment, is among the most valuable and cost-effective diagnostic tools. Patients record each morning: time of going to bed, estimated time to fall asleep, number and duration of nighttime awakenings, final wake time, estimated total sleep time, subjective sleep quality rating, and any relevant factors (stress level, alcohol, medications, exercise). The diary provides objective data that is far more reliable than retrospective recall, identifies patterns not apparent from a single consultation, and serves as a baseline against which treatment effects can be measured.

Validated Assessment Instruments

Standardized, validated questionnaires support clinical assessment and allow quantification of symptom severity:

For insomnia severity:

• Insomnia Severity Index (ISI): A 7-item self-report questionnaire that quantifies the severity of sleep onset, sleep maintenance, and early morning awakening difficulties, their impact on daytime functioning, and the patient’s distress about them. Scores of 8–14 indicate subthreshold insomnia, 15–21 moderate insomnia, and 22–28 severe insomnia.
• Pittsburgh Sleep Quality Index (PSQI): A 19-item questionnaire assessing multiple dimensions of sleep quality over the past month.

For anxiety:

• GAD-7 (Generalized Anxiety Disorder-7): A 7-item validated screen for GAD severity.
• HAM-A (Hamilton Anxiety Rating Scale): A clinician-administered scale assessing both psychic and somatic anxiety.

For depression (given the frequent comorbidity):

• PHQ-9 (Patient Health Questionnaire-9)

Laboratory Investigations

Targeted blood tests may be ordered to exclude organic conditions that mimic anxiety or disrupt sleep:

• Thyroid function tests (TSH, free T4): Hyperthyroidism causes anxiety, palpitations, insomnia; hypothyroidism causes fatigue, depression, cognitive slowing
• Complete blood count: Anemia is a common and easily missed cause of fatigue and sleep disturbance
• Iron studies and ferritin: Iron deficiency is associated with Restless Legs Syndrome and worsens fatigue
• Vitamin B12 and folate: Deficiencies can cause mood disturbance, cognitive impairment, and sleep difficulties
• Vitamin D: Severe deficiency is associated with fatigue and mood disturbance
• Fasting blood glucose and HbA1c: Diabetes can cause nocturia and sleep disruption
• Cortisol and adrenal function: Cushing’s syndrome and other hypercortisolemic states disrupt sleep architecture
• Caffeine use assessment: While not a blood test, detailed caffeine intake history is essential

Advanced Sleep Studies

For most patients with anxiety-related insomnia, the above clinical assessment is sufficient. However, in specific clinical scenarios, more specialized investigations are warranted:

• Actigraphy: A wrist-worn accelerometer worn continuously for 1 to 2 weeks that objectively records movement patterns as a proxy for sleep-wake cycles. Provides objective data complementing sleep diary records and is particularly useful for detecting circadian rhythm disorders.
• Polysomnography (PSG): The gold-standard objective sleep investigation, conducted in a sleep laboratory with continuous overnight recording of brain activity (EEG), eye movements (EOG), muscle tone (EMG), heart rhythm (ECG), breathing effort, nasal/oral airflow, oxygen saturation, and body position. PSG is not required for the diagnosis of typical insomnia but is indicated when:
  • Obstructive sleep apnea is suspected (witnessed apneas, heavy snoring, significant daytime sleepiness despite adequate sleep opportunity)
  • Restless Legs Syndrome or periodic limb movement disorder is suspected
  • Parasomnias (sleepwalking, sleep terrors, REM sleep behavior disorder) require characterization
  • The clinical picture is atypical or treatment-resistant

---

Treatment

Modern treatment of anxiety-related insomnia has evolved substantially beyond simply prescribing sleeping tablets. The therapeutic goal is not merely to induce sleep temporarily, but to restore natural, self-sustaining sleep by addressing the underlying hyperarousal, learned avoidance behaviors, and dysfunctional beliefs that perpetuate the disorder. The approach is almost always multimodal, combining behavioral, psychological, and, when appropriate, pharmacological interventions tailored to the individual patient’s presentation.

Cognitive Behavioral Therapy for Insomnia (CBT-I)

CBT-I is the recommended first-line treatment for chronic insomnia by virtually all major sleep and psychiatric professional bodies, including the American Academy of Sleep Medicine, the European Sleep Research Society, and NICE in the UK. Critically, multiple high-quality clinical trials demonstrate that CBT-I produces superior long-term outcomes compared to sleeping medication, without the risks of dependence, tolerance, or rebound insomnia that complicate pharmacological management.

CBT-I is typically delivered over 4 to 8 sessions (individually, in groups, or increasingly through validated digital platforms) and comprises several distinct but complementary components:

Sleep Restriction Therapy

One of the most powerful and counterintuitive CBT-I techniques. Patients are initially prescribed a time-in-bed window that matches their actual sleep time (typically identified from the sleep diary), rather than the extended time in bed they may be spending in ineffective attempts to get more sleep. This temporary mild sleep restriction:

• Builds homeostatic sleep pressure (the biological drive for sleep that accumulates during wakefulness) rapidly.
• Consolidates sleep into a more continuous, efficient block.
• Breaks the pattern of extended wakefulness in bed that reinforces the association between bed and wakefulness.

The time-in-bed window is then gradually expanded as sleep efficiency improves.

Stimulus Control Therapy

Based on the principle that the bed and bedroom have, through repeated pairings with wakefulness, worry, and frustration, become conditioned stimuli for arousal rather than for sleep. The goal is to rebuild the association between the bedroom and sleep. Key instructions include:

• Use the bed only for sleep and sex, not for working, reading, watching TV, using smartphones, or worrying.
• Get out of bed if you are awake for more than approximately 20 minutes. Go to another room and engage in a quiet, non-stimulating activity until sleepy, then return.
• Maintain a consistent wake time every morning, regardless of how much sleep was obtained. This is the single most important instruction for resetting the circadian clock.
• Avoid prolonged daytime napping

Cognitive Restructuring

Addresses the maladaptive beliefs and cognitive distortions about sleep that maintain insomnia and sleep-related anxiety. Common targets include:

• Catastrophizing: “If I don’t sleep, tomorrow will be a disaster and I won’t be able to function”
• Unrealistic expectations: “I absolutely must get 8 hours or I won’t be healthy”
• Hypermonitoring: Constant attention to internal sleep-related cues (heart rate, physical sensations, alertness level)
• Misattribution: “My insomnia is caused by a physical problem that nothing can fix”

The therapist helps the patient identify these thoughts, examine the evidence for and against them, and develop more realistic, balanced alternative perspectives.

Sleep Hygiene Education

While sleep hygiene alone is not sufficient to treat established insomnia (its effects as a standalone intervention are modest), education about sleep-promoting behaviors provides an important framework:

• Maintaining consistent sleep and wake times
• Creating an optimal sleep environment (dark, cool, quiet)
• Avoiding screens before bed
• Managing caffeine and alcohol intake
• Appropriate timing and intensity of exercise

Relaxation Training

Teaches specific techniques to reduce the physiological arousal that prevents sleep onset:

• Progressive Muscle Relaxation (PMR): Systematic tensing and releasing of muscle groups to produce deep physical relaxation
• Diaphragmatic breathing: Slow, deep abdominal breathing that activates the parasympathetic nervous system
• Imagery rehearsal: Guided mental imagery of peaceful, non-arousing scenes
• Autogenic training: A relaxation technique using verbal self-suggestions of warmth and heaviness

Mindfulness-Based Approaches

Mindfulness-Based Cognitive Therapy for Insomnia (MBCT-I) integrates mindfulness meditation principles with CBT-I components. Mindfulness teaches patients to observe racing thoughts and physical sensations with non-judgmental awareness, neither trying to suppress them nor being carried away by them. This reduces the secondary suffering caused by struggling against insomnia. This approach is particularly valuable for patients in whom worry and rumination are prominent maintaining factors.

Digital CBT-I (dCBT-I)

Validated digital CBT-I programs (apps and web-based platforms) have demonstrated efficacy comparable to in-person CBT-I in several clinical trials, with the major advantages of accessibility, scalability, availability at any hour, and lower cost. These programs are an important option for patients who face barriers to accessing in-person therapy (geographical remoteness, cost, waitlists, or scheduling constraints).

Pharmacological Treatments

Medications for insomnia should be considered as an adjunct to behavioral treatment rather than a primary or standalone therapy. Pharmacological treatment is most appropriate for:

• Short-term relief during acute, identifiable stressors while behavioral therapy is initiated
• Patients who cannot immediately access CBT-I
• Patients with severe insomnia that requires rapid symptom control for safety or functioning reasons
• As an augmentation strategy when CBT-I alone produces insufficient improvement

All sleep medications should be used at the lowest effective dose, for the shortest effective duration, with a clear plan for tapering and discontinuation, and with regular reassessment of ongoing need.

Orexin Receptor Antagonists (DORAs)

Representing the most clinically significant recent advance in insomnia pharmacotherapy, dual orexin receptor antagonists (DORAs) such as suvorexant (Belsomra) and lemborexant (Dayvigo) work through an entirely different mechanism from traditional sedative-hypnotics. Rather than non-specifically sedating the brain, they specifically block the orexin (hypocretin) wake-promoting signaling system, essentially removing the biochemical “signal to stay awake” rather than forcibly inducing unconsciousness.

Clinical advantages:

• More physiologically natural sleep architecture compared to traditional sedatives
• Reduced morning grogginess (“hangover effect”) compared to benzodiazepines
• Lower abuse potential and no significant physical dependence
• Effective for both sleep onset and sleep maintenance insomnia
• FDA-approved and increasingly available internationally

Melatonin and Melatonin Receptor Agonists

Melatonin (the pineal hormone that signals biological night-time) has a modest role in insomnia treatment, most appropriately for:

• Circadian rhythm disruption (jet lag, shift work, delayed sleep phase syndrome)
• Older adults (over 55), in whom endogenous melatonin production is often reduced, and in whom prolonged-release melatonin (Circadin) has demonstrated efficacy in clinical trials
• As a chronobiotic (a timing-shifting agent), taking melatonin at the appropriate time relative to the desired sleep phase

It is important to note that melatonin is not a conventional sedative; it does not act as a hypnotic in the manner of benzodiazepines. It works by signaling to the body that it is nighttime, nudging the circadian clock. It is most useful when circadian misalignment is the primary problem.

Ramelteon, a melatonin receptor agonist, has similar properties and is FDA-approved for sleep onset insomnia.

Benzodiazepines and Z-Drugs

Benzodiazepines (diazepam, lorazepam, temazepam, triazolam) and non-benzodiazepine hypnotics (so-called Z-drugs: zolpidem, zaleplon, zopiclone, eszopiclone) enhance GABA-ergic inhibitory neurotransmission, producing sedation, anxiolysis, and muscle relaxation. They are effective at rapidly inducing and maintaining sleep.

However, their use is associated with significant concerns that limit their appropriateness for longer-term management:

• Tolerance: Efficacy diminishes with regular use, typically within days to weeks, requiring dose escalation.
• Dependence and addiction: Both psychological and physical dependence develop with regular use, with potential for serious withdrawal symptoms (including seizures) upon abrupt discontinuation.
• Rebound insomnia: Discontinuation after regular use causes a temporary worsening of insomnia, which can trap patients in prolonged use.
• Residual sedation and cognitive impairment: Next-day “hangover”, impaired driving and machinery operation ability, increased fall risk (particularly in the elderly), memory impairment
• Sleep architecture disruption: These agents suppress deep slow-wave sleep and REM sleep, which are the most restorative sleep stages.

Current guidelines recommend benzodiazepines and Z-drugs only for short-term use (typically no more than 2–4 weeks), for specific acute situations, and at the lowest effective dose. They should not be prescribed for chronic insomnia management.

Antidepressants and Anxiolytics for Comorbid Conditions

When insomnia coexists with a clinically significant anxiety disorder or depression (which is extremely common), treating the underlying psychiatric condition is itself a critical component of sleep disorder management:

• SSRIs and SNRIs: First-line pharmacological treatment for most anxiety disorders and depression. However, as noted, they can initially worsen insomnia, and some patients experience vivid dreams. These effects usually resolve over the first few weeks of treatment.
• Mirtazapine: An antidepressant with prominent sedating and appetite-stimulating effects, particularly useful when insomnia, reduced appetite, and depression coexist.
• Trazodone: A serotonin antagonist and reuptake inhibitor (SARI) widely used at sub-antidepressant doses as a non-habit-forming sleep aid, particularly for sleep maintenance insomnia.
• Low-dose doxepin: A tricyclic antidepressant approved at very low doses specifically for sleep maintenance insomnia (Silenor). This is distinct from its use at higher doses as an antidepressant.
• Quetiapine (Seroquel): Although not formally approved for primary insomnia, this atypical antipsychotic is widely prescribed off-label for insomnia in the context of psychiatric comorbidities, particularly when other options have failed.
• Buspirone: A non-sedating anxiolytic effective for GAD. It does not directly treat insomnia, but by reducing daytime anxiety, it can attenuate the worry and arousal that drives sleep disruption in GAD patients.
• Hydroxyzine: A first-generation antihistamine with anxiolytic and sedative properties, used off-label for anxiety and insomnia. It carries a lower risk of dependence than benzodiazepines.

Lifestyle Changes and Sleep Hygiene

The success of any pharmacological or psychotherapeutic treatment is powerfully enhanced or undermined by daily lifestyle choices. Sleep hygiene is not merely cosmetic advice. It reflects evidence-based behavioral strategies that optimize the biological conditions required for healthy sleep.

Consistent Sleep Schedule

Maintaining the same wake time every morning, including weekends and vacations, is the single most powerful sleep hygiene intervention. The circadian clock (the biological pacemaker in the suprachiasmatic nucleus of the hypothalamus) functions optimally when anchored by consistent light exposure and social timing cues. A consistent wake time synchronizes the clock, builds appropriate homeostatic sleep pressure by bedtime, and prevents the “social jet lag” caused by drastically different weekend sleep schedules.

Light Management

• Morning bright light exposure: Within 30 to 60 minutes of the desired wake time, exposure to bright light (ideally natural sunlight; otherwise a 10,000 lux light therapy box) powerfully advances and reinforces the circadian phase by signaling “morning” to the biological clock.
• Evening light restriction: Blue-wavelength light from smartphones, tablets, computers, and LED televisions suppresses melatonin secretion and advances the phase of the circadian clock, delaying sleep onset. Limiting screen use for 1 to 2 hours before the desired bedtime, or using blue-light filtering glasses and screen settings, reduces this interference.
• Dim the bedroom: The sleeping environment should be as dark as possible, as even small amounts of light can suppress melatonin and fragment sleep.

Bedroom Environment Optimization

• Temperature: The optimal sleeping room temperature for most adults is approximately 16–18°C (60–65°F). Core body temperature must fall by approximately 1°C to initiate sleep, and a cool environment facilitates this cooling.
• Noise: Consistent background noise (white noise, pink noise, or a fan) can mask disruptive intermittent sounds and promote sleep maintenance.
• Bedding and mattress: Should be comfortable and supportive. Replacing an old, uncomfortable mattress is a worthwhile investment in sleep quality.

Caffeine and Alcohol

• Caffeine: A potent adenosine receptor antagonist, it blocks the accumulation of adenosine (the primary sleep-promoting molecule that builds throughout the day). Caffeine has a half-life of approximately 5 to 6 hours in most adults (longer in some individuals, shorter in others based on genetic metabolism differences). Consuming caffeine in the afternoon or evening can significantly delay sleep onset. As a practical guideline, caffeine intake should ideally cease by early afternoon (12:00 to 14:00) for most people with sleep difficulties.
• Alcohol: Perhaps the most commonly misused “sleep aid”. Alcohol does initially produce sedation, reducing the time to fall asleep. However, as it is metabolized during the night (typically after 4–5 hours), it causes rebound arousal, REM sleep rebound, increased wakefulness, nightmares, and early morning awakening. Regular alcohol use significantly worsens overall sleep architecture and quality. It also worsens obstructive sleep apnea. For individuals with insomnia, alcohol should be eliminated as a sleep aid and ideally avoided within 3 to 4 hours of bedtime.

Physical Exercise

Regular moderate-intensity aerobic exercise is one of the most effective non-pharmacological interventions for both insomnia and anxiety. Exercise:

• Increases adenosine buildup and homeostatic sleep pressure
• Reduces cortisol and promotes parasympathetic tone
• Improves mood and reduces anxiety, both of which facilitate sleep
• Improves overall physical health, reducing the somatic discomforts that can disrupt sleep

Timing matters: Vigorous exercise within 2 to 3 hours of bedtime can delay sleep onset due to the elevation in core body temperature and sympathetic activation it produces. Morning or early afternoon exercise is optimal for most individuals with insomnia.

Relaxation Techniques and Integrative Medicine

For individuals whose sleep is disrupted primarily by anxiety and physiological hyperarousal, structured relaxation practices can be highly effective as stand-alone or adjunctive interventions:

Mindfulness Meditation

Regular mindfulness meditation practice, even brief daily sessions of 10 to 20 minutes, has demonstrated robust evidence of benefit for anxiety and sleep. Mindfulness trains the capacity to observe anxious thoughts and physical sensations with acceptance rather than struggle, reducing the secondary suffering caused by fighting against them. Mindfulness-Based Stress Reduction (MBSR) programs (typically 8 weeks) and various app-based mindfulness tools (Headspace, Calm, Insight Timer) provide accessible entry points.

Progressive Muscle Relaxation (PMR)

Systematic progressive tensing and releasing of muscle groups throughout the body, typically practiced over 20 to 30 minutes, produces deep physical relaxation. This can effectively reduce the muscular tension that both reflects and reinforces anxiety. Regular practice before bedtime can meaningfully reduce sleep-onset difficulty.

Diaphragmatic Breathing and Physiological Sigh

Slow, deep diaphragmatic (abdominal) breathing activates the parasympathetic nervous system, reducing heart rate, blood pressure, and cortisol. The physiological sigh (a double inhale through the nose followed by a slow, extended exhale through the mouth) has been shown to rapidly and powerfully reduce physiological stress arousal. Practicing these techniques during pre-sleep routines can facilitate the transition from the alertness of the day to the relaxed state conducive to sleep onset.

Yoga

Regular yoga practice, particularly restorative yoga and yoga nidra (yogic sleep), has demonstrated benefits for both anxiety and sleep quality in multiple clinical studies. The combination of controlled movement, breathwork, and meditative attention makes yoga an effective stress-reduction and sleep-promoting practice.

Herbal Remedies and Supplements

Some patients seek herbal or natural sleep-promoting supplements. While generally safer than pharmaceutical sedatives, these preparations are not without considerations:

• Valerian root: Modest evidence for mild anxiolytic and sleep-promoting effects. Generally well-tolerated; may take 2 to 4 weeks of regular use to produce noticeable benefit. Considered safe for short-term use.
• Passionflower (Passiflora incarnata): Some evidence of anxiolytic and mild sedative effects; traditional use as a calming herb. Generally well-tolerated.
• Lavender (oral preparations such as Silexan): Several randomized controlled trials demonstrate efficacy for generalized anxiety and improved sleep quality.
• Magnesium glycinate or magnesium threonate: Magnesium plays a role in GABA-ergic function; supplementation may reduce physiological anxiety symptoms and improve sleep in those with deficiency.

Important caveat: Herbal preparations are not regulated to the same standards as pharmaceutical medications in most countries. Purity, potency, and quality vary considerably between products and manufacturers. They should be discussed with a prescribing physician, particularly because some (notably valerian) can interact with other medications or enhance the sedative effects of prescription drugs.

---

Frequently Asked Questions

Does anxiety cause insomnia, or does insomnia cause anxiety?

Both are possible and well-documented. Anxiety causes insomnia by producing physiological and cognitive hyperarousal at bedtime. Racing thoughts, elevated cortisol, and heightened sympathetic nervous system activity all impair sleep onset and maintenance. Conversely, insomnia causes and worsens anxiety by impairing the brain’s ability to regulate emotional responses, increasing amygdala reactivity, and reducing prefrontal cortical inhibitory control. In most people who experience both conditions, a self-reinforcing vicious cycle develops in which each condition perpetuates and worsens the other.

What is CBT-I and is it better than sleeping pills?

Cognitive Behavioral Therapy for Insomnia (CBT-I) is a structured psychological treatment specifically designed to address the behavioral and cognitive factors that maintain chronic insomnia. Multiple high-quality clinical trials demonstrate that CBT-I produces better long-term outcomes than sleeping medication. Improvements are sustained for months and years after treatment completion, rather than ending when the medication is stopped. CBT-I also carries none of the risks of dependence, tolerance, or rebound insomnia associated with pharmacological treatments. Current international guidelines recommend CBT-I as the first-line treatment for chronic insomnia.

Are sleeping pills safe for long-term use?

Traditional sleeping medications, including benzodiazepines and Z-drugs (such as zolpidem and zopiclone), are not recommended for long-term use. With regular use, tolerance develops (requiring higher doses for the same effect), physical and psychological dependence can occur, and abrupt discontinuation can cause withdrawal symptoms including rebound insomnia and (in severe cases) seizures. These medications also disrupt normal sleep architecture. Newer agents such as orexin receptor antagonists have a more favorable long-term safety profile, but even these are best used in the context of behavioral treatment rather than as a standalone long-term solution.

How much sleep do adults actually need?

Most adults need 7 to 9 hours of sleep per night to function optimally. However, individual variation is significant. Some healthy individuals genuinely function well on 6 hours, while others need 9 or 10. The key indicators are not the number on the clock but whether you feel rested upon waking, can function well through the day without excessive tiredness, and do not regularly need an alarm clock or catch up on sleep during weekends. Contrary to popular belief, sleep needs do not substantially decrease with aging.

---

Sources and Bibliography

• Anxiety and Depression Association of America (ADAA) – Sleep Disorders
• Riemann D, et al. European guideline for the diagnosis and treatment of insomnia. Journal of Sleep Research, 2017 (European Sleep Research Society – ESRS).
• Qaseem A, et al. Management of Chronic Insomnia Disorder in Adults: A Clinical Practice Guideline From the American College of Physicians. Annals of Internal Medicine, 2016.
• Perlis ML, et al. Cognitive Behavioral Treatment of Insomnia: A Session-by-Session Guide. Springer, 2005.
• Walker M. Why We Sleep: Unlocking the Power of Sleep and Dreams. Scribner, 2017.
• Harvey AG. A cognitive model of insomnia. Behaviour Research and Therapy, 2002.
• Kloss JD, et al. Sleep, sleep disturbance, and fertility in women. Sleep Medicine Reviews, 2015.
• Irwin MR. Why sleep is important for health: a psychoneuroimmunology perspective. Annual Review of Psychology, 2015.
• Cappuccio FP, et al. Meta-analysis of short sleep duration and obesity in children and adults. Sleep, 2008.
• Van Someren EJW. Brain mechanisms of insomnia: New perspectives on causes and consequences. Physiological Reviews, 2021.
• Morin CM, et al. Cognitive-behavior therapy singly and combined with medication for persistent insomnia. JAMA, 2009.
• National Sleep Foundation: Sleep Health
• American Academy of Sleep Medicine (AASM)